From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development

We often hear headlines about breakthrough discoveries and promising new therapies for herpes — only to hear nothing more about them months or even years later. Why do so manyContinueContinue reading “From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development”

🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨

There’s major progress happening in the fight against HSV-2. Assembly Biosciences (ASMB) has reported very promising interim results from two Phase 1b clinical studies testing their new investigational treatments forContinueContinue reading “🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨”

2025 Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk

Liu Y, Johnston C, Jarousse N, et al Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study BMJ Open 2025;15:e093946. doi: 10.1136/bmjopen-2024-093946 Here are our key takeaways from the studyContinueContinue reading “2025 Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk”

New Therapeutic Strategies for Genital Herpes: NIH Initiative

The National Institute of Health (NIH) is ramping up efforts to improve treatments for genital herpes with a new funding opportunity. Current treatment options are limited, often failing to completelyContinueContinue reading “New Therapeutic Strategies for Genital Herpes: NIH Initiative”

Early Phase 1a clinical trials show potential for long-acting antiherpetic drugs.

Assembly Biosciences announced the most exciting results of the first phase 1a clinical trial of their most advanced helicase primase inhibitor, ABI-5366 (registered as clinical trial NCT06385327). The results exceededContinueContinue reading “Early Phase 1a clinical trials show potential for long-acting antiherpetic drugs.”

NEW STUDY AND ANALYSIS: Breakthrough in Understanding of Viral Infection and Neurodegenerative Disease

The COVID-19 pandemic, along with the neurological complications seen in long COVID patients, has brought renewed attention to the possible link between viral infections and neurodegenerative diseases. Although viruses likeContinueContinue reading “NEW STUDY AND ANALYSIS: Breakthrough in Understanding of Viral Infection and Neurodegenerative Disease”

Herpes Impact on Brain Health: New study indicates Shringix Vaccine prevents dementia

Experts insist we are at a tipping point in scientific research relating to herpesviruses impact on dementia and Alzheimer’s Disease. Last month a new study from a team in AustraliaContinueContinue reading “Herpes Impact on Brain Health: New study indicates Shringix Vaccine prevents dementia”